Lava Therapeutics NVLVTX
13F holders, Q1 2024 (March 31)20holders
1famous investor
$3.33avg. 13F price*
At the end of Q1 2024, 20 institutions reported holding Lava Therapeutics NV (LVTX) in their 13F filings. The largest holders were Redmile Group, LLC ($6.9M), Bruce & Co., Inc. ($2.6M) and Sphera Funds Management LTD. ($1.2M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Lava Therapeutics NV
- CUSIP
- N51517105
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $2.3M |
| Exits | 5 | $4.3M |
Ownership 20 holders
| Redmile Group, LLC | 0.25% | No change | 2,074,372 | $6.9M |
| Bruce & Co., Inc. | 0.86% | No change | 771,874 | $2.6M |
| Sphera Funds Management LTD. | 0.20% | New | 367,582 | $1.2M |
| Walleye Capital LLC | 0.01% | New | 154,666 | $515K |
| Alpha Wave Global, LP | 0.11% | No change | 107,906 | $359K |
| Two Sigma Investments, LP | 0.00% | New | 82,031 | $273K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 65,000 | $216K |
| Millennium Management | 0.00% | Reduce -28.6% | 20,028 | $67K |
| Schonfeld Strategic Advisors LLC | 0.00% | New | 18,300 | $61K |
| Two Sigma Advisers, LP | 0.00% | New | 16,700 | $56K |
| Bank of America Corp. | 0.00% | New | 15,411 | $51K |
| Pathway Financial Advisors LLC | 0.01% | New | 14,000 | $47K |
| Two Sigma Securities, LLC | 0.00% | New | 12,908 | $43K |
| Geode Capital Management, LLC | 0.00% | No change | 11,124 | $37K |
| Morgan Stanley | 0.00% | Reduce -58.9% | 10,200 | $34K |
| UBS Group AG | 0.00% | New | 8,980 | $30K |
| CIBC Private Wealth Group LLC | 0.00% | New | 6,000 | $20K |
| Simplex Trading, LLC | 0.00% | Add +488.4% | 2,589 | $8K |
| Cutler Group LLC / CA | 0.00% | New | 1,000 | $3K |
| Tsfg, LLC | 0.00% | No change | 400 | $1K |
"% of holder's portfolio" is LVTX's weight in each manager's 13F, not the share of Lava Therapeutics NV the manager owns.